Just In
- 6 hrs ago Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style!
- 7 hrs ago From Alia Bhatt To Kriti Sanon, Korean Beauty Products That Bollywood Divas Swear By
- 10 hrs ago Exclusive: On World Malaria Day 2024, Dr Shares Danger Signs Parents Must Watch Out For In Child With Malaria
- 10 hrs ago Exclusive: Expert Debunks 5 Common Misconceptions About Expectant Mothers That You Need To Steer Clear From
Don't Miss
- Sports T20 World Cup 2024: Toss up between Sanju Samson and KL Rahul ahead of big selection meeting
- Finance IndusInd Bank Q4 Results: PAT Soars 15% To Rs 2,349 Cr, NII Climbs 15%; 165% Dividend Declared
- Movies Dance Deewane 4: Madhuri Dixit, Suniel Shetty, Karisma Kapoor Dance On Chak Dhoom Dhoom With Chikoo, Bunty- PI
- News Who Is Lisa Pisano, New Jersey Woman Gets Pig Kidney Transplant And Heart Pump?
- Automobiles Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here
- Technology Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos
- Education AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
Tick Saliva Drug May Lower HIV-Linked Heart Disease Risk
Read to know how tick saliva can be used to lower heart disease risk.
An experimental drug made from tick saliva may hold promise as a potential treatment for reducing HIV-linked heart disease risk, a study has found. Scientists at the University of Pittsburgh and National Institutes of Health (NIH) in the US have found a clue to why people living with HIV have double the likelihood of developing heart disease.
The increased heart disease risk is driven by a subset of immune cells in people with HIV which continue to express a protein that triggers blood clotting and inflammation even after the HIV virus is under control by medication, they said. The researchers found that Ixolaris, an experimental drug isolated from tick saliva and previously tested to treat blood clots in animals, successfully reduced the inflammation in monkeys infected with SIV, the primate form of HIV.
"This treatment has the potential to improve the clinical management of HIV-infected patients and help them to live longer, healthier lives with HIV," said Ivona Pandrea, professor at Pitt's Center for Vaccine Research. "By uncovering one of the cellular mechanisms driving the heart disease, we can look for medications - such as Ixolaris - that specifically target and disrupt that mechanism," said Pandrea, senior author of the study published in the journal Science Translational Medicine.
Irini Sereti, of the NIH's National Institute of Allergy and Infectious Diseases (NIAID), tested blood samples from people without HIV, people with HIV whose infections were well-controlled by antiretroviral therapy and people with HIV who were not on the medications. The researchers found an elevated number of immune cells called monocytes that expressed high levels of the 'tissue factor' protein, which is associated with blood clotting and other inflammatory proteins, in the blood from people with HIV, regardless of how well their infection was controlled.
These findings were confirmed by Pandrea and her team in monkeys that progress to AIDS after infection with SIV. The same cells isolated from a different species of monkey that usually does not develop heart disease when infected with SIV do not produce tissue factor, thus reinforcing the role of this damaging protein in triggering cardiovascular disease in the HIV/SIV settings.
The scientists then exposed the human blood samples to Ixolaris and observed that the drug blocked the activity of tissue factor. When tested in a small group of monkeys during early SIV infection, the treatment significantly lowered the levels of inflammatory proteins linked to cardiovascular diseases.
- healthThe Hidden Dangers of Migraine: Heart Disease and Stroke
- healthHow To Manage Stress And High Blood Pressure In The First Place
- healthCancer, Heart Disease Vaccine To Be Ready By 2030: Know More Here
- wellnessHeart Failure: Can Social Relationships Improve Recovery? Here’s What We Know
- wellnessIrregular Menstrual Cycles Linked With Cardiovascular Diseases (CVD), Study
- wellnessRecurring Hot Flashes May Be A Sign Of Increased Heart Disease Risk
- wellnessCDC's 7 Strategies To Live A Heart-Healthy Lifestyle
- wellnessWorld-Leading Scientists On The Brink Of Curing Genetic Heart Diseases For The First Time In History
- disorders cureHeart Disease Risk And Depression: A New Study Explores Whether The Two May Be Linked
- disorders cureWhat Is Broken Heart Syndrome (Stress Cardiomyopathy)? Causes, Symptoms And Treatment
- disorders cureFirst Patient Who Received Pig Heart Transplant Dies After Two Months
- wellnessPeople With Heart Defects May Be At Higher Risk For Severe COVID: Study